Landauer, a provider of personal and environmental radiation monitoring services, has acquired all outstanding equity interests of US-based IZI Medical Products for around $93m.
IZI Medical develops quality medical consumable accessories used in radiology, radiation therapy, and image-guided surgery procedures.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The purchasing is done through refinancing of Landauer’s existing debt with a new $175m revolving debt facility with a term of five years.
IZI Medical Products CEO Helen Shafer said that IZI Medical expands Landauer’s addressable market opportunities in both the US and international markets.
Landauer president and CEO Bill Saxelby added, "The acquisition is an excellent strategic fit and enhances our radiation safety continuum offering."
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
